相关实验视频

Updated: Sep 14, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

由认知定义的注意力缺陷/多动性障碍亚型具有明显的神经和临床特征,并且对阿托莫克赛丁的反应有所不同

John E Leikauf¹, Kristi R Griffiths², Simon D Clarke³

¹Stanford University School of Medicine, Stanford, California.

Journal of the American Academy of Child and Adolescent Psychiatry

|July 18, 2025

概括

这项研究根据认知表现确定了两种不同的注意力缺陷/多动障碍 (ADHD) 亚型. 一个亚型的特征是抑制控制受损,它表现出特定的神经模式,对阿托莫克赛丁的反应更好.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
遗传学遗传学是一个

背景情况:

注意缺陷/多动障碍 (ADHD) 已因其异质性而得到认可.
了解ADHD的各种表现对于有效治疗至关重要.
以前的研究表明,基于认知特征,可能存在ADHD亚型.

研究的目的:

为了识别ADHD的不同认知亚型.
通过神经生理学 (qEEG,心率),临床 (症状) 和治疗反应数据来验证这些亚型.
为了研究对阿托莫克西和甲基酸盐的不同反应.

主要方法:

在初始样本中对认知措施 (抑制控制,持续的注意力,工作记忆) 的等级集群分析.
在单独的临床样本中复制已识别的集群.
评估神经相关物 (qEEG,心率),临床症状 (ADHD,焦虑),以及对阿托莫克西和甲基酸的治疗反应.

主要成果:

确定了ADHD的两个可复制的认知亚型.
抑制控制亚型表现出明显的qEEG模式 (增加的Delta,Theta,Beta活动) 和更高的静止心率.
与持续注意力亚型相比,这种亚型也表现出更严重的焦虑和显著更好的对阿托莫克赛丁的反应.

结论:

认知分析有效地识别出具有独特神经支的ADHD亚型.
这些认知亚型对ADHD药物的反应不同.
抑制控制亚型可能特别受益于非兴奋剂治疗,如阿托莫克赛丁.

关键词:

更多关于 ADHD ADHD 的文章认知认知是一种认知.亚托莫克西丁 (atomoxetine) 是一种药物.电脑脑电图 (EEG) 是一种电脑电图.甲基基化甲基化

更多相关视频

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol

Published on: April 1, 2018

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

相关概念视频

Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...

Autism Spectrum Disorder

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...